It is characteristic, that the immunohistochemical detection of VEGF-C and VEGF-D in stage II/III colorectal adenocarcinoma varies between 43%-77% and 50%-64% [49,50] respectively. The gene discussed is VEGFD; the disease is colorectal adenocarcinoma.